Gait and balance disorders are cardinal features of corticobasal syndrome (CBS), distinguishing it from other parkinsonian disorders and contributing significantly to disability, falls, and reduced quality of life. Unlike the symmetric, shuffling gait typical of Parkinson's disease (PD), CBS gait abnormalities are typically asymmetric and develop alongside cortical signs such as apraxia, alien limb, and cortical sensory loss.
Early falls within the first 1-2 years of symptom onset are a hallmark feature of CBS, occurring more rapidly than in progressive supranuclear palsy (PSP) or PD[@wu2022]. The combination of cortical motor dysfunction, basal ganglia impairment, and parietal lobe involvement creates a unique gait phenotype that reflects the underlying pathological heterogeneity of CBS.
Falls occur within 12-24 months of symptom onset in the majority of CBS patients, significantly earlier than in PSP (where falls typically occur 3-4 years after onset) or PD (where falls may occur 5-10+ years into the disease)[@wu2022]. Several factors contribute to this early fall tendency:
The frequency of falls increases over time, with >80% of CBS patients experiencing falls by year 3 of the disease.
CBS demonstrates several characteristic gait patterns that differ from other parkinsonian syndromes:
Asymmetric Gait
The most distinctive feature is marked asymmetry, with one side more affected than the other. The more-affected side typically shows:
This asymmetry reflects the unilateral cortical and basal ganglia involvement characteristic of CBS and helps distinguish it from PSP, where gait impairment is typically symmetric[@boehm2019].
Reduced Arm Swing
Arm swing is diminished on the side contralateral to the more-affected hemisphere. Unlike PD, where arm swing reduction is bilateral, CBS preserves arm swing on the less-affected side. This pattern correlates with the asymmetric cortical atrophy seen on MRI.
En-bloc Freezing
Some CBS patients develop freezing of gait (FOG), characterized by sudden, transient inability to initiate or continue walking. This is thought to relate to:
FOG in CBS may be less prominent than in PD but can be disabling when present.
Magnetic Gait
A subset of patients develop magnetic gait — shuffling with reduced floor clearance, where feet appear to "stick" to the floor. This reflects severe bradykinesia and rigidity, typically in more advanced disease stages.
Postural instability in CBS results from multiple mechanisms:
The pull test (retropulsion test) shows impaired recovery in most CBS patients, typically earlier than in PSP. However, the pattern of fall differs: CBS patients tend to fall laterally or to the more-affected side, while PSP patients fall backward (retropulsion).
Balance deficits in CBS are multifactorial:
| Factor | Contribution |
|---|---|
| Cortical sensory loss | Impaired body position awareness |
| Visuospatial dysfunction | Spatial orientation deficits |
| Vestibular dysfunction | Impaired balance reflexes |
| Apraxia | Inability to execute compensatory movements |
| Impaired anticipatory postural control | Delayed protective responses |
Gait and balance impairment in CBS reflects dysfunction in multiple neural circuits:
Basal Ganglia Motor Circuit
Supplementary Motor Area (SMA) Circuit
Premotor and Motor Cortex
Parietal Lobule
| Feature | CBS | PSP | PD |
|---|---|---|---|
| Fall timing | Early (1-2 years) | Mid (3-4 years) | Late (5-10+ years) |
| Symmetry | Asymmetric | Symmetric | Symmetric |
| Fall direction | Lateral/to affected side | Backward | Variable |
| Arm swing | Asymmetric reduction | Bilateral reduction | Bilateral reduction |
| Freezing | Moderate | Prominent | Prominent |
| Postural reflexes | Impaired early | Severely impaired | Preserved early |
Given emerging evidence of vestibular involvement in CBS[@chen2023], comprehensive assessment includes:
Limited efficacy of dopaminergic medications in CBS means alternatives are often tried:
| Agent | Rationale | Evidence |
|---|---|---|
| Levodopa | May help if dopamine deficiency contributes | Modest benefit in ~30% of cases |
| Amantadine | NMDA antagonism | May reduce rigidity/bradykinesia |
| Clonazepam | GABAergic, may help myoclonus | Can improve sleep and mild benefit |
| Botulinum toxin | For associated dystonia | May improve gait if dystonia is limiting |
Physical Therapy
Occupational Therapy
Selection of assistive devices should consider CBS-specific factors:
For patients with documented vestibular dysfunction[@chen2023]:
Current research areas include:
Gait and balance disorders in CBS are early, prominent, and disabling features that reflect the unique combination of cortical, basal ganglia, and parietal dysfunction in this condition. The asymmetric presentation, early falls within 1-2 years, and distinct patterns of postural instability help differentiate CBS from PSP and PD. Management requires a multidisciplinary approach combining physical therapy, occupational therapy, vestibular rehabilitation, and appropriate assistive devices. Understanding the neural circuits underlying gait impairment will guide future therapeutic developments for this challenging aspect of CBS.